ALZTEV 13.3/24 Transdermal Patch Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

alztev 13.3/24 transdermal patch

teva pharma b.v. - rivastigmine base - transdermal patch - 13.3/24 - anticholinesterases

EMERPAND 4.6 mg/24 hours Transdermal Patch Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

emerpand 4.6 mg/24 hours transdermal patch

actavis group ptc ehf - rivastigmine - transdermal patch - 4.6 mg/24 hours - anticholinesterases

EMERPAND 9.5 mg/24 hours Transdermal Patch Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

emerpand 9.5 mg/24 hours transdermal patch

actavis group ptc ehf - rivastigmine - transdermal patch - 9.5 mg/24 hours - anticholinesterases

EMERPAND 13.3 mg/24 hours Transdermal Patch Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

emerpand 13.3 mg/24 hours transdermal patch

actavis group ptc ehf - rivastigmine - transdermal patch - 13.3 mg/24 hours - anticholinesterases

Nimvastid Euroopa Liit - inglise - EMA (European Medicines Agency)

nimvastid

krka, d.d., novo mesto - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia. symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.,

Rivastigmine 1 A Pharma Euroopa Liit - inglise - EMA (European Medicines Agency)

rivastigmine 1 a pharma

1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Rivastigmine Hexal Euroopa Liit - inglise - EMA (European Medicines Agency)

rivastigmine hexal

hexal ag  - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Rivastigmine Sandoz Euroopa Liit - inglise - EMA (European Medicines Agency)

rivastigmine sandoz

sandoz gmbh - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Rivastigmine Actavis Euroopa Liit - inglise - EMA (European Medicines Agency)

rivastigmine actavis

actavis group ptc ehf - rivastigmine hydrogen tartrate - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Exelon 4.6mg24hours transdermal patches Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

exelon 4.6mg24hours transdermal patches

novartis pharmaceuticals uk ltd - rivastigmine - transdermal patch - 4.6mg/24hour